Correlation Between Mineralys Therapeutics, and Cingulate
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Cingulate, you can compare the effects of market volatilities on Mineralys Therapeutics, and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Cingulate.
Diversification Opportunities for Mineralys Therapeutics, and Cingulate
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Cingulate is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Cingulate go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Cingulate
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Cingulate. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.47 times less risky than Cingulate. The stock trades about -0.05 of its potential returns per unit of risk. The Cingulate is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 434.00 in Cingulate on August 28, 2024 and sell it today you would earn a total of 2.00 from holding Cingulate or generate 0.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Cingulate
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Cingulate |
Mineralys Therapeutics, and Cingulate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Cingulate
The main advantage of trading using opposite Mineralys Therapeutics, and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |